 differenti effect sodium butyr hexamethylen bisacetamid growth secret cultur human endocrin tumor cell advanc gastrointestin endocrin tumor convent chemotherapi studi effect agent cellular differenti sodium butyr hexamethylen bisacetamid vitro growth secretori respons human pancreat carcinoid bon human gastrinoma pt-sm cell line laboratori sodium butyr hexamethylen inhibit growth bon pt-sm cell continu exposur bon cell butyr mmol/l time hour control hour satur densiti control hexamethylen bisacetamid mmol/l satur densiti control bon cell doubl time hour hour antiprolif effect similar magnitud gastrinoma cell line contrast differenti effect amin biosynthesi bon cell sodium butyr level cell wherea profound dose-depend inhibit amin biosynthesi signific antiprolif activ sodium butyr hexamethylen bisacetamid inhibitori effect hexamethylen bisacetamid amin biosynthesi warrant evalu agent analogu treatment metastat carcinoid gastrinoma